Back to Search

MONIQUE GURNEY, PHARMD

PHARMD

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist

NPI: 1942962790Individual

Specialties, Licenses & Credentials

Pharmacist Clinician (PhC)/ Clinical Pharmacy SpecialistPrimary

Pharmacist — Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist

Code: 1835P0018X

5337139-1701(UT)

Research & Publications (20)

Cultural competence in health care: what is it?
PMID 16566303·S D Med·2006
6-review
What transgenic mice tell us about neurodegenerative disease.
PMID 10684590·Bioessays·2000
6-review
The group B streptococcal serine-rich repeat 1 glycoprotein mediates penetration of the blood-brain barrier.
PMID 19392623·J Infect Dis·2009
7-preclinical
Antagonists of the EP3 receptor for prostaglandin E2 are novel antiplatelet agents that do not prolong bleeding.
PMID 19193156·ACS Chem Biol·2009
7-preclinical
3-Acrylamide-4-aryloxyindoles: synthesis, biological evaluation and metabolic stability of potent and selective EP3 receptor antagonists.
PMID 19188065·Bioorg Med Chem Lett·2009
4-observational
Peri-substituted hexahydro-indolones as novel, potent and selective human EP3 receptor antagonists.
PMID 19121942·Bioorg Med Chem Lett·2009
7-preclinical
3,4-Disubstituted indole acylsulfonamides: a novel series of potent and selective human EP3 receptor antagonists.
PMID 19022669·Bioorg Med Chem Lett·2009
8-other
Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.
PMID 19618939·J Med Chem·2009
8-other
DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease.
PMID 19012178·Platelets·2008
8-other
DcpS as a therapeutic target for spinal muscular atrophy.
PMID 18839960·ACS Chem Biol·2008
8-other
Selective killing of nonreplicating mycobacteria.
PMID 18329613·Cell Host Microbe·2008
7-preclinical
Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
PMID 18205293·J Med Chem·2008
7-preclinical
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes.
PMID 17460697·Nat Genet·2007
4-observational
Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/- knock-outs compared with wild-type mice.
PMID 17460065·J Neurosci·2007
7-preclinical
A poke in the eye.
PMID 18220056·Nurs Older People·2007
8-other
Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial.
PMID 15886380·JAMA·2005
3-trial
Primary esophageal melanoma in a patient with limited scleroderma.
PMID 16357719·J Clin Rheumatol·2005
5-case
The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke.
PMID 14770184·Nat Genet·2004
8-other
Screening for presenilin inhibitors using the free-living nematode, Caenorhabditis elegans.
PMID 15006138·J Biomol Screen·2004
7-preclinical
Chiropractic-primary care, neuromusculoskeletal care, or musculoskeletal care? Results of a survey of chiropractic college presidents, chiropractic organization leaders, and Connecticut-licensed doctors of chiropractic.
PMID 14569217·J Manipulative Physiol Ther·2003
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
100 N MARIO CAPECCHI DR
SALT LAKE CITY, UT 84113

Location

Practice Location

100 N MARIO CAPECCHI DR, SALT LAKE CITY, UT
(801) 662-1680

Quick Facts

NPI
1942962790
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile